- Advertisement -
The rise of weight loss drugs such as Ozempic and Wegovy has added momentum to Australian fitness technology company Evolt which has just raised $20 million in fresh capital to drive international growth ahead of a potential stock market listing.
The Gold Coast-based Evolt, formerly known as…
